The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cholera Vaccine (Oral Route) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cholera Vaccine (Oral Route) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Cholera Vaccine (Oral Route) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Shanchol segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cholera Vaccine (Oral Route) include PaxVax, Sanofi, Valneva, EuBiologics, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cholera Vaccine (Oral Route) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Shanchol
Dukoral
Vaxchora
Others
Market segment by Application can be divided into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Cholera Vaccine (Oral Route) market are listed below:
PaxVax
Sanofi
Valneva
EuBiologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cholera Vaccine (Oral Route) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cholera Vaccine (Oral Route), with price, sales, revenue and global market share of Cholera Vaccine (Oral Route) from 2019 to 2022.
Chapter 3, the Cholera Vaccine (Oral Route) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccine (Oral Route) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cholera Vaccine (Oral Route) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cholera Vaccine (Oral Route).
Chapter 13, 14, and 15, to describe Cholera Vaccine (Oral Route) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cholera Vaccine (Oral Route) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Cholera Vaccine (Oral Route) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Shanchol segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cholera Vaccine (Oral Route) include PaxVax, Sanofi, Valneva, EuBiologics, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cholera Vaccine (Oral Route) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Shanchol
Dukoral
Vaxchora
Others
Market segment by Application can be divided into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Cholera Vaccine (Oral Route) market are listed below:
PaxVax
Sanofi
Valneva
EuBiologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cholera Vaccine (Oral Route) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cholera Vaccine (Oral Route), with price, sales, revenue and global market share of Cholera Vaccine (Oral Route) from 2019 to 2022.
Chapter 3, the Cholera Vaccine (Oral Route) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccine (Oral Route) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cholera Vaccine (Oral Route) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cholera Vaccine (Oral Route).
Chapter 13, 14, and 15, to describe Cholera Vaccine (Oral Route) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Cholera Vaccine (Oral Route) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cholera Vaccine (Oral Route) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cholera Vaccine (Oral Route) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Cholera Vaccine (Oral Route) Market Size & Forecast
1.4.1 Global Cholera Vaccine (Oral Route) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cholera Vaccine (Oral Route) Sales in Volume (2017-2028)
1.4.3 Global Cholera Vaccine (Oral Route) Price (2017-2028)
1.5 Global Cholera Vaccine (Oral Route) Production Capacity Analysis
1.5.1 Global Cholera Vaccine (Oral Route) Total Production Capacity (2017-2028)
1.5.2 Global Cholera Vaccine (Oral Route) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cholera Vaccine (Oral Route) Market Drivers
1.6.2 Cholera Vaccine (Oral Route) Market Restraints
1.6.3 Cholera Vaccine (Oral Route) Trends Analysis
2 Manufacturers Profiles
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Cholera Vaccine (Oral Route) Product and Services
2.1.4 PaxVax Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cholera Vaccine (Oral Route) Product and Services
2.2.4 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Cholera Vaccine (Oral Route) Product and Services
2.3.4 Valneva Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Cholera Vaccine (Oral Route) Product and Services
2.4.4 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cholera Vaccine (Oral Route) Breakdown Data by Manufacturer
3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cholera Vaccine (Oral Route) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cholera Vaccine (Oral Route)
3.4 Market Concentration Rate
3.4.1 Top 3 Cholera Vaccine (Oral Route) Manufacturer Market Share in 2021
3.4.2 Top 6 Cholera Vaccine (Oral Route) Manufacturer Market Share in 2021
3.5 Global Cholera Vaccine (Oral Route) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cholera Vaccine (Oral Route) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cholera Vaccine (Oral Route) Market Size by Region
4.1.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2017-2028)
4.1.2 Global Cholera Vaccine (Oral Route) Revenue by Region (2017-2028)
4.2 North America Cholera Vaccine (Oral Route) Revenue (2017-2028)
4.3 Europe Cholera Vaccine (Oral Route) Revenue (2017-2028)
4.4 Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2017-2028)
4.5 South America Cholera Vaccine (Oral Route) Revenue (2017-2028)
4.6 Middle East and Africa Cholera Vaccine (Oral Route) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Type (2017-2028)
5.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2017-2028)
5.3 Global Cholera Vaccine (Oral Route) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Application (2017-2028)
6.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2017-2028)
6.3 Global Cholera Vaccine (Oral Route) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cholera Vaccine (Oral Route) Sales by Type (2017-2028)
7.2 North America Cholera Vaccine (Oral Route) Sales by Application (2017-2028)
7.3 North America Cholera Vaccine (Oral Route) Market Size by Country
7.3.1 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2017-2028)
7.3.2 North America Cholera Vaccine (Oral Route) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cholera Vaccine (Oral Route) Sales by Type (2017-2028)
8.2 Europe Cholera Vaccine (Oral Route) Sales by Application (2017-2028)
8.3 Europe Cholera Vaccine (Oral Route) Market Size by Country
8.3.1 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2017-2028)
8.3.2 Europe Cholera Vaccine (Oral Route) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2017-2028)
9.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2017-2028)
9.3 Asia-Pacific Cholera Vaccine (Oral Route) Market Size by Region
9.3.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cholera Vaccine (Oral Route) Sales by Type (2017-2028)
10.2 South America Cholera Vaccine (Oral Route) Sales by Application (2017-2028)
10.3 South America Cholera Vaccine (Oral Route) Market Size by Country
10.3.1 South America Cholera Vaccine (Oral Route) Sales in Volume by Country (2017-2028)
10.3.2 South America Cholera Vaccine (Oral Route) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2017-2028)
11.2 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2017-2028)
11.3 Middle East & Africa Cholera Vaccine (Oral Route) Market Size by Country
11.3.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cholera Vaccine (Oral Route) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cholera Vaccine (Oral Route)
12.3 Cholera Vaccine (Oral Route) Production Process
12.4 Cholera Vaccine (Oral Route) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cholera Vaccine (Oral Route) Typical Distributors
13.3 Cholera Vaccine (Oral Route) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cholera Vaccine (Oral Route) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cholera Vaccine (Oral Route) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Cholera Vaccine (Oral Route) Product and Services
Table 6. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Cholera Vaccine (Oral Route) Product and Services
Table 10. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Valneva Basic Information, Manufacturing Base and Competitors
Table 12. Valneva Major Business
Table 13. Valneva Cholera Vaccine (Oral Route) Product and Services
Table 14. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 16. EuBiologics Major Business
Table 17. EuBiologics Cholera Vaccine (Oral Route) Product and Services
Table 18. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Cholera Vaccine (Oral Route) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Cholera Vaccine (Oral Route) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Cholera Vaccine (Oral Route), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Cholera Vaccine (Oral Route) Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Cholera Vaccine (Oral Route) Production Site of Key Manufacturer
Table 24. Cholera Vaccine (Oral Route) New Entrant and Capacity Expansion Plans
Table 25. Cholera Vaccine (Oral Route) Mergers & Acquisitions in the Past Five Years
Table 26. Global Cholera Vaccine (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 27. Global Cholera Vaccine (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 28. Global Cholera Vaccine (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Cholera Vaccine (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 31. Global Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 32. Global Cholera Vaccine (Oral Route) Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Cholera Vaccine (Oral Route) Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Cholera Vaccine (Oral Route) Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Cholera Vaccine (Oral Route) Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 37. Global Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 38. Global Cholera Vaccine (Oral Route) Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Cholera Vaccine (Oral Route) Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Cholera Vaccine (Oral Route) Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Cholera Vaccine (Oral Route) Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 43. North America Cholera Vaccine (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 44. North America Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Cholera Vaccine (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 47. North America Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 48. North America Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 49. North America Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 50. Europe Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 51. Europe Cholera Vaccine (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 52. Europe Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Cholera Vaccine (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 55. Europe Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 56. Europe Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 57. Europe Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Cholera Vaccine (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 66. South America Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 67. South America Cholera Vaccine (Oral Route) Sales by Country (2023-2028) & (K Units)
Table 68. South America Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Cholera Vaccine (Oral Route) Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 71. South America Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 72. South America Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 73. South America Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2023-2028) & (K Units)
Table 82. Cholera Vaccine (Oral Route) Raw Material
Table 83. Key Manufacturers of Cholera Vaccine (Oral Route) Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Cholera Vaccine (Oral Route) Typical Distributors
Table 87. Cholera Vaccine (Oral Route) Typical Customers
List of Figures
Figure 1. Cholera Vaccine (Oral Route) Picture
Figure 2. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type in 2021
Figure 3. Shanchol
Figure 4. Dukoral
Figure 5. Vaxchora
Figure 6. Others
Figure 7. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Research & Academic Laboratories
Figure 10. Pharmaceutical & Biotechnology Companies
Figure 11. Others
Figure 12. Global Cholera Vaccine (Oral Route) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Cholera Vaccine (Oral Route) Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Cholera Vaccine (Oral Route) Sales (2017-2028) & (K Units)
Figure 15. Global Cholera Vaccine (Oral Route) Price (2017-2028) & (USD/Unit)
Figure 16. Global Cholera Vaccine (Oral Route) Production Capacity (2017-2028) & (K Units)
Figure 17. Global Cholera Vaccine (Oral Route) Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Cholera Vaccine (Oral Route) Market Drivers
Figure 19. Cholera Vaccine (Oral Route) Market Restraints
Figure 20. Cholera Vaccine (Oral Route) Market Trends
Figure 21. Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturer in 2021
Figure 22. Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturer in 2021
Figure 23. Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Cholera Vaccine (Oral Route) Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2028)
Figure 27. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2017-2028)
Figure 28. North America Cholera Vaccine (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 29. Europe Cholera Vaccine (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Cholera Vaccine (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 31. South America Cholera Vaccine (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Cholera Vaccine (Oral Route) Revenue (2017-2028) & (USD Million)
Figure 33. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2028)
Figure 34. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2017-2028)
Figure 35. Global Cholera Vaccine (Oral Route) Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 37. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2017-2028)
Figure 38. Global Cholera Vaccine (Oral Route) Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2028)
Figure 40. North America Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 41. North America Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2028)
Figure 42. North America Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 43. United States Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2028)
Figure 47. Europe Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 48. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2028)
Figure 49. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 50. Germany Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Cholera Vaccine (Oral Route) Revenue Market Share by Region (2017-2028)
Figure 59. China Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2028)
Figure 66. South America Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 67. South America Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2028)
Figure 68. South America Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Cholera Vaccine (Oral Route) Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Cholera Vaccine (Oral Route) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Cholera Vaccine (Oral Route) in 2021
Figure 80. Manufacturing Process Analysis of Cholera Vaccine (Oral Route)
Figure 81. Cholera Vaccine (Oral Route) Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
